PMID- 34803907 OWN - NLM STAT- MEDLINE DCOM- 20220214 LR - 20230921 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 12 DP - 2021 TI - Metabolically Abnormal But Normal-Weight Individuals Had a Higher Risk of Type 2 Diabetes Mellitus in a Cohort Study of a Chinese Population. PG - 724873 LID - 10.3389/fendo.2021.724873 [doi] LID - 724873 AB - AIMS: Obesity is a heterogeneous disease in terms of body mass index (BMI) and metabolic status. The purpose of this study was to investigate the risk of type 2 diabetes mellitus (T2DM) in subjects with metabolically abnormal but normal weight (MANW) in China. MATERIALS AND METHODS: A prospective cohort with a total of 17,238 participants of the Zhejiang metabolic syndrome cohort was recruited. According to the standard of the Working Group on Obesity in China, general obesity is defined. Metabolic abnormality was defined as two or more abnormal components (elevated triglycerides (TG), low high-density lipoprotein cholesterol (HDL-C), elevated systolic blood pressure (SBP) or diastolic blood pressure (DBP) or use of antihypertensive therapy, and elevated fasting plasma glucose or antidiabetic treatment). The hazard ratio (HR) and its 95% CI were calculated using a multiple regression model, adjusted for the potential confounding factors. RESULTS: Compared with metabolically normal and normal weight (MNNW) subjects, the metabolically abnormal and obesity/overweight (MAO) subjects had the highest risk of T2DM disease, with an HR of 4.67 (95% CI: 3.23-6.76), followed by MANW subjects (HR = 2.61, 95% CI: 1.74-3.92) and metabolically normal but obesity/overweight (MNO) subjects (HR = 2.09, 95% CI: 1.29-3.38) after adjusting for age, sex, smoking, drinking, physical activity, and family history of diabetes. Compared with that in the MNNW subjects, the HR in MANW subjects was significantly higher than that in MNO subjects. In normal-weight subjects, the HR of T2DM was significantly positively correlated with the number of components with metabolic abnormalities. CONCLUSIONS: MANW subjects had a higher risk of T2DM. MANW subjects should be given more attention in the prevention and control of common chronic diseases. CI - Copyright (c) 2021 Chen, Zhou, Dai, Zhao, Zhu and Zhang. FAU - Chen, Qiannan AU - Chen Q AD - Basic Discipline of Chinese and Western Integrative, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China. FAU - Zhou, Yaohan AU - Zhou Y AD - Department of Epidemiology & Biostatistics, School of Public Health, Zhejiang University, Hangzhou, China. FAU - Dai, Chen AU - Dai C AD - Department of Endocrinology and Institute of Cardiovascular Diseases, Putuo District People's Hospital , Zhoushan, China. FAU - Zhao, Gang AU - Zhao G AD - Department of office Hangzhou Center of Disease Control and Prevention, Hangzhou, China. FAU - Zhu, Yimin AU - Zhu Y AD - Department of Epidemiology & Biostatistics, School of Public Health, Zhejiang University, Hangzhou, China. AD - Department of Respiratory Diseases, Sir Run Run Shaw Hospital Affiliated to the School of Medicine, Zhejiang University, Hangzhou, China. FAU - Zhang, Xuhui AU - Zhang X AD - Affiliated Hangzhou Center of Disease Control and Prevention, Zhejiang University School of Public Health, Hangzhou Center for Disease Control and Prevention, Hangzhou, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20211103 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 SB - IM MH - Adult MH - Aged MH - Body Mass Index MH - China/epidemiology MH - Cohort Studies MH - Diabetes Mellitus, Type 2/epidemiology/*etiology MH - Female MH - Follow-Up Studies MH - Humans MH - *Ideal Body Weight MH - Male MH - Metabolic Syndrome/*complications/epidemiology MH - Middle Aged MH - Risk Factors PMC - PMC8595277 OTO - NOTNLM OT - heterogeneity OT - metabolically abnormal but normal weight (MANW) OT - metabolically normal but obesity/overweight (MNO) OT - obesity OT - type 2 diabetes mellitus COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/11/23 06:00 MHDA- 2022/02/15 06:00 PMCR- 2021/01/01 CRDT- 2021/11/22 06:40 PHST- 2021/06/14 00:00 [received] PHST- 2021/10/11 00:00 [accepted] PHST- 2021/11/22 06:40 [entrez] PHST- 2021/11/23 06:00 [pubmed] PHST- 2022/02/15 06:00 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2021.724873 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2021 Nov 3;12:724873. doi: 10.3389/fendo.2021.724873. eCollection 2021.